Literature DB >> 12390974

Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease.

A Priori1, C Cinnante, A Pesenti, M Carpo, A Cappellari, E Nobile-Orazio, G Scarlato, S Barbieri.   

Abstract

The strength-duration function is a classic measure of neural excitability. When studied on peripheral motor axons it reflects the intrinsic nodal membrane properties, and its time-constant (tau(SD) or chronaxie) predominantly depends on non-voltage-gated, rest Na(+) inward conductances. We assessed the strength-duration curve of ulnar motor axons in 22 nerves of healthy controls, in 18 nerves of patients with multifocal motor neuropathy with conduction blocks (MMN), and in 19 nerves of patients with motor neurone disease (MND). The compound muscle action potential (CMAP) was smaller in nerves of both groups of patients than in controls (P < 0.05). The rheobasic current (rh(50%)) [mean +/- standard deviation (SD)] was higher in patients with MMN than in controls (13.3 +/- 16.3 mA; controls 4.7 +/- 1.7 mA, P < 0.05). The tau(SD) was differentially abnormal in the nerves of the two groups of patients: it was prolonged in the nerves of patients with MND for >or=40 years (227.2 +/- 34.5 micro s; controls 190.9 +/- 51.0 micro s, P < 0.05), but it was shortened in the nerves of patients with MMN (146.5 +/- 55.4 micro s; controls 208.6 +/- 51.2 micro s, P < 0.05) who had not been treated recently with high-dose intravenous immunoglobulin (IVIg). Nerves of patients with recently treated MMN (<6 weeks) who were under the therapeutic effect of IVIg had a normal tau(SD)(.) Our results suggest that, probably due to an immuno-mediated rest Na(+) channel dysfunction, Na(+) conductances are reduced in MMN. This abnormality is a function of the time after the last IVIg treatment and involves also the axonal membrane outside the conduction block. Conversely, in MND, possibly owing to the ionic leakage of degenerating membrane, rest Na(+) conductances are increased. Measuring the strength-duration curve of the ulnar motor axons might be useful in the differential diagnosis between de novo MMN and MND.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390974     DOI: 10.1093/brain/awf255

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

Review 2.  Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.

Authors:  Peter J Dyck; Bruce V Taylor; Jenny L Davies; Michelle L Mauermann; William J Litchy; Christopher J Klein; P James B Dyck
Journal:  Muscle Nerve       Date:  2015-08-13       Impact factor: 3.217

Review 3.  The node of Ranvier in multifocal motor neuropathy.

Authors:  Hessel Franssen
Journal:  J Clin Immunol       Date:  2014-05-08       Impact factor: 8.317

Review 4.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

Review 5.  Intravenous immunoglobulin treatment in multifocal motor neuropathy.

Authors:  W-Ludo van der Pol; Elisabeth A Cats; Leonard H van den Berg
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

6.  Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy.

Authors:  Satish V Khadilkar; Shrikant S Deshmukh; Pramod D Dhonde
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

Review 7.  Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.

Authors:  Melvin Berger; Jeffrey A Allen
Journal:  Muscle Nerve       Date:  2015-01-29       Impact factor: 3.217

Review 8.  Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.

Authors:  Melvin Berger; Daniel E McCallus; Cindy Shin-Yi Lin
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

9.  Amyotrophic lateral sclerosis: a dying motor unit?

Authors:  Maria Piotrkiewicz; Irena Hausmanowa-Petrusewicz
Journal:  Front Aging Neurosci       Date:  2013-03-26       Impact factor: 5.750

Review 10.  MMN: from immunological cross-talk to conduction block.

Authors:  Oliver Harschnitz; Bas A Jongbloed; Hessel Franssen; Dirk C G Straver; W Ludo van der Pol; Leonard H van den Berg
Journal:  J Clin Immunol       Date:  2014-04-13       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.